The Japanese pharmaceutical industry, a vital component of global innovation, faces a talent gap that resonates across multinational corporations. While Japan possesses a wealth of highly skilled professionals, a notable communication disparity impedes recruitment and career advancement, particularly in global…
HOME > LATEST
LATEST
-
BUSINESS Japan Vaccine Market to Reach 297 Billion Yen in FY2025: Fuji Keizai
June 13, 2025
-
BUSINESS SanBio Inches Closer to Cell Therapy Shipment with Partial Change Filing
June 13, 2025
-
BUSINESS Nippon Chemiphar to Launch Amaryl AGs on June 20
June 13, 2025
-
BUSINESS Takeda’s Livmarli, HyQvia Now Available in Japan
June 13, 2025
-
BUSINESS Boehringer Files Nerandomilast for Pulmonary Fibrosis in Japan
June 13, 2025
-
BUSINESS Pfizer Pushes Back Champix Re-Supply Plan on Regulatory Delay
June 12, 2025
-
REGULATORY Latest Honebuto Draft Erases “Expansion” of CEA after LDP Pushback
June 12, 2025
-
BUSINESS AbbVie Japan Looks to Double Sales by 2029 with Rinvoq and Skyrizi as Engines
June 12, 2025
-
BUSINESS Prashant Nikam to Take Over Helm of MSD Japan
June 12, 2025
-
REGULATORY EquMet, Clenafin See Generic Entry in June Listing
June 12, 2025
-
REGULATORY Ruling Bloc, Ishin Agree to Discuss Coverage of OTC-Like Drugs
June 12, 2025
-
REGULATORY Include Repeal of Off-Year Drug Price Revision in Honebuto: DPP
June 12, 2025
-
BUSINESS Takeda Seeks Japan Nod for Vonvendi Use in Patients Under 18
June 11, 2025
-
REGULATORY GSK’s Arexvy Bolsters Label with Long-Term Data
June 11, 2025
-
BUSINESS Enhertu Enters PIII for 1st-Line Endometrial Cancer Use: Daiichi
June 11, 2025
-
BUSINESS Taking on Solid Tumors - 5: Genmab Pursuing Unique T-Cell Engager Program for Lung Cancer
June 11, 2025
-
BUSINESS Taking on Solid Tumors - 4: With 2 Late-Stage Assets in Wings, Will AstraZeneca Reshape CP Inhibitor Landscape?
June 10, 2025
-
REGULATORY LDP Lawmakers Push Back on Honebuto Draft over CEA, Social Security Budgeting
June 10, 2025
-
BUSINESS SSP Files for OTC Switch of Tadalafil in Japan
June 10, 2025
-
ORGANIZATION Hata Comes Back to Helm FIRM after 2 Years
June 10, 2025
ページ
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…